Imunon issues 120 Series B preferred shares in unregistered sale under note exchange

• Imunon entered an exchange with Streeterville Capital to issue 120 shares of Series B Preferred Stock in an unregistered sale.
• The shares were issued at $10,000 each in exchange for $1.2 million of principal on its Secured Promissory Note A-1.
• The exchange reduced obligations under the A-1 Note by the principal and any accrued unpaid interest exchanged.
• Series B Preferred Stock carries a $12,000 stated value with an 8% annual return, payable in cash or additional shares.
• The issuance relied on the Securities Act Section 4(a)(2) private placement exemption.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Imunon Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-044792), on September 29, 2026, and is solely responsible for the information contained therein.